News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
145–178
Matches
178
Sources here
20
Companies here
6
Search results Stored financial headlines

Active search

178 matching headlines

Ticker or company: HEADMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

ARWR Maintained by JP Morgan -- Price Target Raised to $95.00

JP Morgan has maintained an "Overweight" rating for Arrowhead Pharmaceuticals Inc. (ARWR) and raised its price target from $88.00 to $95.00, signaling increased confidence in the company's future. Despite this, GuruFocus data indicates ARWR is currently overvalued by 46.4% based on its GF Value, …

ARWR main company
Sharemaestro market context Trend signal active 52 weeks +306.2% · Next-week setup positive 55.6% ARWR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

J.P. Morgan Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Raises Target Price to $95

J.P. Morgan has reiterated its Buy rating on Arrowhead Pharmaceuticals (ARWR.US) and increased its price target for the company to $95. This revised target suggests potential upside for investors in Arrowhead Pharmaceuticals.

ARWR main company
Sharemaestro market context Trend signal active 52 weeks +306.2% · Next-week setup positive 55.6% ARWR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

6 Red Days In A Row: Arrowhead Pharmaceuticals Stock Is Down 17%

Arrowhead Pharmaceuticals (ARWR) stock has dropped 17.4% over six consecutive trading days, resulting in a $2.2 billion market value decrease. This decline is company-specific, as the S&P 500 gained 0.9% during the same period, and is attributed to strained profitability metrics despite high historical …

ARWR main company
Sharemaestro market context Trend signal active 52 weeks +306.2% · Next-week setup positive 55.6% ARWR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

First Community And 2 Other Stocks Estimated To Be Trading Below Their Intrinsic Value

This article identifies First Community (FCCO), Heritage Financial (HFWA), and Bowhead Specialty Holdings (BOW) as undervalued U.S. stocks based on discounted cash flow analysis. Despite a generally flat U.S. market recently, these companies show significant estimated discounts to fair value, strong forecasted earnings growth, …

BOW main company
Sharemaestro market context Trend signal active 52 weeks +5.6% · Next-week setup negative 39.4% BOW stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Wasatch Advisors reports 8% stake in Goosehead Insurance (NASDAQ: GSHD)

Wasatch Advisors has reported an 8% beneficial ownership stake in Goosehead Insurance Inc. (NASDAQ: GSHD), totaling 1,892,453 Class A shares. The firm holds sole voting power over 1,332,999 shares and sole dispositive power over all 1,892,453 shares, as disclosed in a SCHEDULE 13G/A filing …

GSHD main company
Sharemaestro market context Trend signal started 52 weeks -25.9% GSHD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Goosehead Insurance, Inc. to Report Second Quarter 2026 Results

Goosehead Insurance, Inc. (NASDAQ: GSHD) announced it will report its second quarter 2026 financial results after the market close on Wednesday, July 22, 2026. The company will host a conference call at 4:30 PM ET on the same day to discuss the results, with …

GSHD main company
Sharemaestro market context Trend signal started 52 weeks -25.9% GSHD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context